Call for Abstracts

Abstract Submission Categories

Submit an Abstract

General and Duel in Dermatopathology Abstract submission - NOW OPEN

• Submission Deadline: May 15, 2024 by 11:59 p.m. Eastern
• Notices of abstract acceptance in the General and Duel categories will be sent out mid-June.
• If you do not receive an email notification by June 30, contact ASDP Staff at [email protected]. 

Dermatopathology Fellows submission - Opening July 15, 2024

• Submission Deadline: Tuesday, August 15, 2024 by 11:59 p.m. Eastern
• Notices of abstract acceptance in the Fellows category will be sent out in early-September.
• If you do not receive an email notification by September 8, contact ASDP Staff at [email protected].

The American Society of Dermatopathology designates this educational activity for AMA PRA Category 1 Credit™. 

About the Call for Abstracts

The ASDP Call for Abstracts offers three categories of abstract submissions for participants interested in presenting their abstract(s) in an educational session at the Annual Meeting.

• The General Abstract category is open to all physicians who practice dermatopathology, including residents and fellows. Abstracts will be selected for either oral or poster presentation.
• The Duel in Dermatopathology category is an oral abstract competition designed especially for residents in dermatology and pathology. Duel abstracts not selected for the competition will be automatically considered for poster presentation.
• The Dermatopathology Fellows Abstract category is open to fellows in a dermatopathology training program. Abstracts will be selected for either oral or poster presentation.

Abstract Submission Criteria

Abstract submissions must adhere to the published submission criteria:

• Abstract content must not have been previously presented, submitted or accepted for presentation at another meeting or previously published in any journal. Abstract content that has been accepted for publication but has not yet been published may be submitted. If work has been published by the time of presentation, this information must be disclosed at the time of presentation to the audience.
• The same abstract may not be submitted in more than one category. Submissions in the General, Duel and Fellow abstract categories will be automatically considered for a poster if not accepted as an oral presentation. Submissions to the General abstract category may be made as “poster-only” for those not wanting to be considered for oral presentation.
• The subject material must be dermatopathology-related, medically and scientifically valid, and should contain new information not previously reported or novel information about the pathophysiology or diagnosis that enhances the understanding of the disease.
• Abstract titles must be clear and accurately reflect the content of the abstract.
• The abstract must adequately summarize the key scientific content of the presentation.
  • The hypothesis should be clearly stated.
  • Scientific methods must be sound and clearly articulated.
  • Appropriate data and observations should be clearly presented.
  • Results must be clearly presented and conclusions must accurately reflect the results and directly address the hypothesis.
• Institutions and personal or institutional identifiers must not be referenced in the abstract.
• All financial relationships in the past 24 months must be disclosed at the time of abstract submission and must be mitigated prior to abstract being accepted for presentation. Financial relationships must not introduce bias in the study design.
• The content must be free of grammatical and spelling errors.
• Non-scientific abstracts will be evaluated on a case-by-case basis.

Abstract Submission Instructions

• Abstracts must be submitted online.
• Abstract content and related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of ineligible companies*.
• Be sure to read the instructions before entering your abstract online.
• Abstract text must not to exceed 250 words.
• Late submissions will not be accepted.
• By submitting an abstract, you agree to make yourself available for the presentation slot to which your abstract is assigned, in the event your abstract is accepted.
• Abstracts accepted for oral or poster presentation will be published to the ASDP website.
• IMPORTANT! Changes cannot be made to your abstract once the submission site (specific to abstract category) has closed. This includes change to authors, title, content, category, and spelling.
• To ensure that you receive notification emails, please add [email protected] to your address book. If you do not receive a notification, check your spam/junk folder before contacting ASDP. With increased security on institutional email, use of personal email address for notification emails is strongly recommended.

‎*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, ‎or distributing healthcare products used by or on patients.‎

Abstract Submission Category Descriptions

General Abstract Category

• Open to all physicians.
• Abstracts must be extraordinary case reports, clinical studies or basic science. Each abstract type has been defined below for reference:
• Case Report - Case reports consider observational description of up to three patients’ diagnoses that may also include discussion of disease management. Case reports usually describe an unusual or novel dermatologic, dermatopathologic or pathologic diagnoses or occurrence of the disease, typically in the context of literature review.
• Clinical Study - Clinical studies encompass research using human tissues or volunteers that advances medical knowledge relating to pathologic diagnosis, management or treatment of dermatologic or systemic disease with cutaneous presentation. These include studies on 4 or more patients or patients’ material. Interventional, observational, as well as experimental studies are included in this category. In extraordinary conditions, work related to dermatopathology using animal models will be considered.
• Basic Science - Basic science research relating to dermatopathology, dermatologic disease or systemic disease with cutaneous presentation.

Duel in Dermatopathology Resident Abstract Competition

• Open only to dermatology and pathology residents. Residents submitting abstracts in this category must be residents at the time of presentation.
• Abstracts must describe a single case report, including clinical and pathologic findings.

Dermatopathology Fellows Abstract Category

• Open only to fellows in a dermatopathology training program. Dermatopathology fellows submitting abstracts in this category must be enrolled in a fellowship training program at the time of presentation.
• Abstracts must be extraordinary case reports, clinical studies or basic science.
• Dermatopathology fellows' abstracts will be accepted between July 5 - August 15, 2024.

Abstract Evaluation Criteria

Abstracts will be evaluated based on the submission criteria using a seven-point scale ranging from poor (1) to outstanding (7). Abstracts will be blind reviewed by all members of the Abstract Review Committee, and the average score will be used to rank the priority of the presentation.

Abstracts will be evaluated using the following criteria:

• Outstanding and Excellent:
• strong data and conclusions
• excellent, error-free writing
• original content/new information
• exceptional teaching value

• Very Good:
• strong data and conclusions
• no errors
• well-written, with good detail and organization
• unusual or rare content

• Average:
• valid to solid data and conclusions
• no errors
• logical to strong writing with detail
• no novel material/relatively common entity or somewhat unusual material

• Fair and Poor:
• weak, incomplete or questionable validity of data and/or conclusions
• minor to significant errors
• weak to poor writing
• common or inconsequential material

To adhere to the new Accreditation Council for Continuing Medical Education (ACCME) Standards (accme.org/standards), abstract presenters' financial relationships will be reviewed and mitigated, prior to abstracts being accepted for presentation.

Abstract Selection Process

If your abstract is not selected for an oral presentation, it will automatically be considered for a poster presentation. The Abstract Review Committee reserves the right to assign oral presentations as appropriate.

Status Notification

All notifications will be sent by email. It is the submitter’s responsibility to ensure his/her email address is correct and current. ASDP is not responsible for confirmations not received due to incorrect contact information. An email confirmation will be sent upon successful submission of an abstract. A separate email indicating the status of General and Duel abstract acceptance will be sent before July 1. Dermatopathology Fellows will be notified of their abstract acceptance in early September.

If your abstract is accepted for poster presentation, you will be notified of your assigned poster number in mid-September.

All oral and poster abstract presenters will be asked to confirm receipt of their notification email and officially accept the invitation to present their abstract. To ensure that you receive notification emails, please add [email protected] to your address book. If you do not receive a notification email, check your spam/junk folder before contacting ASDP. With increased security on institutional email, use of personal email address for notification emails is strongly recommended.

Meeting Registration

All presenters (oral and poster) are required to pay the meeting registration fee. ASDP does not provide reimbursement to speakers for registration or travel expenses. The Annual Meeting Preliminary Program will be published online and online registration will be available in June. For up-to-date meeting information, visit the ASDP meeting website often.

About Abstract Presentations

Abstract submitters must read the CME Activity Policies Manual before submitting their ‎‎abstract.

Both oral and poster presenters must disclose to learners verbally and visually, ‎immediately ‎prior to the ‎presentation, all relevant financial ‎relationships or lack thereof (using ‎a slide ‎embedded ‎in their presentation slide deck‎ or a disclosure statement on poster presentation).

Presenters must also ensure ‎that the content of their presentations promotes improvements ‎or quality in ‎healthcare ‎and not a specific proprietary business ‎interest of a commercial ‎interest.‎ Presentations must ‎give a fair and balanced view of ‎therapeutic and diagnostic ‎options based on scientific ‎‎methods generally accepted by the medical community ‎and any ‎clinical content presented ‎must support safe, ‎effective patient care‎.

About Oral Presentations

It is very important that speakers keep within the allotted time. Below is the schedule for all of the oral abstract sessions for the 61st Annual Meeting:

• Oral Abstract Session 1
  (Virtual session consisting of all non-trainee presenters)
  Thursday, November 7: 10:30 a.m. - 12:30 p.m. Central

• 25th Duel in Dermatopathology Resident Abstract Competition
  (In-person session)
  Friday, November 8: 1:00 p.m. - 2:30 p.m. Central

• Fellows' Presentations
  (In-person session)
  Friday, November 8: 5:30 p.m. - 7:30 p.m. Central

• Oral Abstract Session 2
  (In-person session consisting of all physician-in-training presenters)
  Saturday, November 9: 1:30 p.m. - 3:30 p.m. Central

About Poster Presentations

We will be holding an in-person poster session at the 61st Annual Meeting. Poster set-up will be held between 10:00 a.m. - 3:00 p.m. on Thursday, November 7. In-person poster viewing will open at 3:00 p.m. that Thursday.

In-Person Poster Schedule

Thursday, November 7
Poster Session Set-up: 10:00 a.m. - 3:00 p.m. Central
Poster Viewing: 3:00 p.m. - 11:59 p.m. Central

Friday, November 8
Poster Viewing: 6:00 a.m. - 11:59 p.m. Central

Saturday, November 9
Poster Viewing: 6:00 a.m. - 11:59 p.m. Central
Poster Defense Session: 3:30 p.m. - 5:30 p.m. Central

Sunday, November 10
Poster Viewing: 6:00 a.m. - 11:00 a.m. Central
Poster Dismantle: 11:00 a.m. - 12:00 p.m. Central

Digital posters

Poster presenters will also need to provide a digital poster to include on our virtual meeting platform.

Digital posters must:

• Be a high-resolution, one-page PDF file and the file size should not exceed 3 MBs.
• Include a disclosure statement. Be sure to disclose in writing any financial relationships with ineligible companies in your poster. If you do not have any relevant relationships to disclose, you must also note it in writing on your poster (ex. “Disclosure Statement: I do not have any relevant relationships to disclose” will suffice). See the CME Activity Policies Manual for examples of ineligible companies. This is an ACCME requirement, and posters lacking a disclosure statement will be disqualified from participating.

Poster Defense Session

This year's meeting will include a two-hour defense. This session will provide an opportunity for discussion between poster presenters and attendees in-person. Poster presenters are asked to make every effort to be at their poster during this defense session. Format of the defense is subject to change pending any social distancing guideline updates.

• Poster Defense
  (In-person)
  Saturday, November 9: 3:30 p.m. – 5:30 p.m. Central

Physicians-in-Training Awards

Physicians-in-Training (residents and fellows-in-training) will be able to select one of their submitted abstracts to be considered for the Physicians-in-Training Award, regardless of abstract category (General, Duel or Dermatopathology Fellow). You must select "Yes" for the question, 'Would you like this abstract to be considered for the Physicians-in-Training Award?' at the time of abstract submission and the abstract should be designated as either a case report or study (including research studies and case series).

Physicians-in-Training Awards will be presented for the best oral and poster presentations. Physicians-in-Training who submit abstracts in the General Abstract Category should be the first author and presenter of the abstract.

The Awards Committee will use the following criteria to evaluate presentations eligible for the Physicians-in-Training Awards:

• Case reports will be judged on the following criteria:
• novelty/teaching value
• quality of description/workup
• impact, potential to change practice
• Studies will be judged on the following criteria:
• conclusions supported by data
• statistical design and analysis
• impact, potential to change practice or influence future research
• All presentations will also be judged on execution, taking into account:
• quality of graphics and images
• accuracy (data accuracy, typos)
• clarity and quality of presentation

The following Physicians-in-Training Awards are given out:

• Top three (3) oral presentations
• Top three (3) poster presentations
• 1st Place, 2nd Place, and 3rd Place in the Duel in Dermatopathology Resident Competition
• Best Case Report and Best Study in the Fellows' Presentations

Questions?

Contact ASDP at [email protected], or +1-847-572-2174.

The American Society of Dermatopathology
[email protected]
Phone: +1-847-572-2188